Financial Ratios CRISPR Therapeutics AG

Revenues

Cost of Goods Sold, Total

Selling General & Admin Expenses, Total

Other Operating Expenses, Total

Interest Expense, Total

Interest And Investment Income

Net Interest Expenses

Income (Loss) On Equity Invest.

Other Non Operating Income (Expenses)

In Process R&D Expenses

Other Unusual Items

Income Tax Expense

Net Income to Company

Minority Interest

Net Income to Common Incl Extra Items

Net Income to Common Excl. Extra Items

Net EPS - Basic

Basic EPS - Continuing Operations

Basic Weighted Average Shares Outstanding

Net EPS - Diluted

Diluted EPS - Continuing Operations

Diluted Weighted Average Shares Outstanding

Normalized Basic EPS

Normalized Diluted EPS

EBITDA

EBITA

EBIT

EBITDAR

Total Revenues (As Reported)

Effective Tax Rate - (Ratio)

Current Domestic Taxes

Current Foreign Taxes

Total Current Taxes

Deferred Domestic Taxes

Total Deferred Taxes

Normalized Net Income

General and Administrative Expenses

Research And Development Expense From Footnotes

Net Rental Expense, Total

Stock-Based Comp., COGS (Total)

Stock-Based Comp., G&A Exp. (Total)

Total Stock-Based Compensation

Cash And Equivalents

Short Term Investments

Accounts Receivable, Total

Other Receivables

Prepaid Expenses

Restricted Cash

Gross Property Plant And Equipment

Accumulated Depreciation

Long-term Investments

Other Intangibles, Total

Other Long-Term Assets, Total

Accounts Payable, Total

Accrued Expenses, Total

Current Portion of Leases

Current Income Taxes Payable

Unearned Revenue Current, Total

Other Current Liabilities

Long-Term Leases

Unearned Revenue Non Current

Other Non Current Liabilities

Common Stock, Total

Additional Paid In Capital

Retained Earnings

Treasury Stock

Comprehensive Income and Other

Total Common Equity

ECS Total Shares Outstanding on Filing Date

ECS Total Common Shares Outstanding

Book Value / Share

Tangible Book Value

Tangible Book Value Per Share

Total Debt

Net Debt

Debt Equivalent Oper. Leases

Account Code - Inventory Valuation

Machinery, Total

Full Time Employees

Net Income

Depreciation & Amortization - CF

Amortization of Goodwill and Intangible Assets - (CF)

Depreciation & Amortization, Total

(Gain) Loss on Sale of Investments - (CF)

Asset Writedown & Restructuring Costs

(Income) Loss On Equity Investments - (CF)

Stock-Based Compensation (CF)

Other Operating Activities, Total

Change In Accounts Receivable

Change In Accounts Payable

Change in Unearned Revenues

Change in Other Net Operating Assets

Capital Expenditure

Cash Acquisitions

Sale (Purchase) of Intangible assets

Investment in Marketable and Equity Securities, Total

Long-Term Debt Issued, Total

Total Debt Issued

Issuance of Common Stock

Repurchase of Common Stock

Issuance of Preferred Stock

Other Financing Activities, Total

Foreign Exchange Rate Adjustments

Miscellaneous Cash Flow Adjustments

Change In Net Working Capital

Net Debt Issued / Repaid